SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the ROC analysis of the SKP2 gene expression suggested that SKP2 gene expression could be an additional diagnostic marker in the context of CML and an independent prognostic marker to predict treatment responses in CML patients at an early time point.